Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON33651
NL-OMON33651
Completed
Not Applicable

A study of the effects of a novel ovarian stimulation regimen on embryo aneuploidy rates in IVF, and the impact of aneuploidy on implantation, as assessed in an in vitro model. - Aneuploidy in IVF embryos and impact on implantation

niversitair Medisch Centrum Utrecht0 sites110 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions10013356embryo aneuploidy1008362410000211

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
10013356
Sponsor
niversitair Medisch Centrum Utrecht
Enrollment
110
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Sponsor
niversitair Medisch Centrum Utrecht

Eligibility Criteria

Inclusion Criteria

  • •Female age \* 39 years
  • •BMI \<32 kg/m2
  • •Regular cycle (25\-35 days)
  • •Standard indication for IVF
  • •No major uterine abnormalities

Exclusion Criteria

  • •Indication for IVF male factor with a total motile sperm count \< 10x106
  • •ICSI or andrological indication
  • •Known abnormal (male or female) karyotype
  • •Oocyte donation
  • •One previous IVF treatment not resulting in embryo transfer
  • •Poor response (\< 4 oocytes obtained at oocyte pick\-up) in the first or second cycle
  • •Female age 39 in case of a previous poor response (\< 4 oocytes obtained at oocyte pick\-up) at the age of 38
  • •History of recurrent abortion

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
Ovarian stimulation protocol with ultra flexible and ultra simplified start for oocyte donorsinfertilityMedDRA version: 20.0Level: PTClassification code 10021926Term: InfertilitySystem Organ Class: 10038604 - Reproductive system and breast disordersTherapeutic area: Body processes [G] - Reproductive physiologi cal processes [G08]
EUCTR2018-003106-29-FRCHI Créteil110
Completed
Not Applicable
effect of ovarian stimulation drugs on incidance of unruptured follicleCondition 1: luteinized unruptured follicle. Condition 2: luteinized unruptured follicle.Female infertility associated with anovulationFemale infertility, unspecified
IRCT2014091019113N1Tehran University Of Medical Sciences180
Not yet recruiting
Phase 3
Investigating the effect of intraovarian administration of platelet rich plasma in patients with poor ovarian response in improving the result of assisted proceduresReducedovarian reserve..Primary ovarian failureE28.3
IRCT20200905048630N5Bandare-abbas University of Medical Sciences88
Completed
Phase 2
Assessment the effect of ovarian stimulation with and without letrozole in IVF/ICSI outcomes.
IRCT201701291952N8Vice Chancellor for research, Tehran University of Medical Science160
Not yet recruiting
Phase 1
Clinical study on improving ovarian function of women with perimenopausal syndrome by Zishui Qinggan Lichong DecoctioPerimenopausal syndrome
ITMCTR2000002899The Third Affiliated Hospital of Beijing University of Chinese Medicine